FANTOM Post Market Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1500 participants.

Also called NCT03587922

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03587922
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Germany, Switzerland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03587922. Allocation not applicable; no masking; primary purpose treatment. Start 2018-05-01 (actual); primary completion 2025-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
FANTOM Post Market Clinical Trial
Intervention (Device)
Fantom
Lead sponsor
REVA Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03587922
Content hash
9c6a9f06ab7c6afd46a47778c90fe37825fd54a695babc884778037631c8edec